Exploring the current use of animal models in glaucoma drug discovery: where are we in 2023?

References

• Agarwal R, Gupta SK, Agarwal P, et al. Current concepts in the pathophysiology of glaucoma. Indian J Ophthalmol. 2009;57(4):257–266. doi: 10.4103/0301-4738.53049
   PubMed Web of Science ®Google Scholar
• Zhang N, Wang J, Chen B, et al. Prevalence of primary angle closure glaucoma in the last 20 years: a meta-analysis and systematic review. Front Med. 2021;7:624179. doi: 10.3389/fmed.2020.624179
   Web of Science ®Google Scholar
• Zhang N, Wang J, Li Y, et al. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11(1):13762. doi: 10.1038/s41598-021-92971-w
   PubMed Web of Science ®Google Scholar
• Agarwal R, Agarwal P. Rodent models of glaucoma and their applicability for drug discovery. Expert Opin Drug Discov. 2017;12(3):261–270. doi: 10.1080/17460441.2017.1281244
   PubMed Web of Science ®Google Scholar
• Pang IH, Clark AF. Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma. 2007 Aug;16(5):483–505. doi: 10.1097/IJG.0b013e3181405d4f
   PubMed Web of Science ®Google Scholar
• Fernandes KA, Harder JM, Williams PA, et al. Using genetic mouse models to gain insight into glaucoma: past results and future possibilities. Exp Eye Res. 2015:141;42–56. doi: 10.1016/j.exer.2015.06.019. .
   PubMed Web of Science ®Google Scholar
• Biswas S, Wan KH. Review of rodent hypertensive glaucoma models. Acta Ophthalmol. 2019;97(3):e331–e340. doi: 10.1111/aos.13983
   PubMed Web of Science ®Google Scholar
• Evangelho K, Mastronardi CA, de-la-Torre A. Experimental models of glaucoma: a powerful translational tool for the future development of new therapies for glaucoma in humans: a review of the literature. Med (Kaunas). 2019 Jun 17;55(6):280. doi: 10.3390/medicina55060280
   PubMed Web of Science ®Google Scholar
• Chen L, Zhao Y, Zhang H. Comparative anatomy of the trabecular meshwork, the optic nerve head and the inner retina in rodent and primate models used for glaucoma research. Vision (Basel). 2016;1(1):4. doi: 10.3390/vision1010004.
   PubMedGoogle Scholar
• Li Y, Semaan SJ, Schlamp CL, et al. Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci. 2007;8(1):19. doi: 10.1186/1471-2202-8-19
   PubMedGoogle Scholar
• Templeton JP, Nassr M, Vazquez-Chona F, et al. Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crush. BMC Neurosci. 2009;10:90. doi: 10.1186/1471-2202-10-90
   PubMed Web of Science ®Google Scholar
• Burroughs SL, Kaja S, Koulen P. Quantification of deficits in spatial visual function of mouse models for glaucoma. Invest Ophthalmol Vis Sci. 2011;52(6):3654–3659. doi: 10.1167/iovs.10-7106
   PubMed Web of Science ®Google Scholar
• Savinova OV, Sugiyama F, Martin JE, et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001;2:12. doi: 10.1186/1471-2156-2-12
   PubMed Web of Science ®Google Scholar
• Bryant CD. The blessings and curses of C57BL/6 substrains in mouse genetic studies. Ann N Y Acad Sci. 2011;1245(1):31–33. doi: 10.1111/j.1749-6632.2011.06325.x
   PubMed Web of Science ®Google Scholar
• Vajaranant TS, Nayak S, Wilensky JT, et al. Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol. 2010;21(2):91–99. doi: 10.1097/ICU.0b013e3283360b7e
   PubMed Web of Science ®Google Scholar
• Rodrigo MJ, Martinez-Rincon T, Subias M, et al. Influence of sex on neuroretinal degeneration: six-month follow-up in rats with chronic glaucoma. Invest Ophthalmol Vis Sci. 2021;62(13):9. doi: 10.1167/iovs.62.13.9
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US). Committee on understanding the biology of sex and gender differences. exploring the biological contributions to human health: does sex matter? Wizemann TM, Pardue ML, editors. (WA) (DC): National Academies Press (US); 2001.
   Google Scholar
• Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev. 2011;35(3):565–572. doi: 10.1016/j.neubiorev.2010.07.002
   PubMed Web of Science ®Google Scholar
• Zucker I, Beery AK. Males still dominate animal studies. Nature. 2010;465(7299):690. doi: 10.1038/465690a
   PubMed Web of Science ®Google Scholar
• Lee SK. Sex as an important biological variable in biomedical research. BMB Rep. 2018;51(4):167–173. doi: 10.5483/BMBRep.2018.51.4.034
   PubMed Web of Science ®Google Scholar
• Beery AK. Inclusion of females does not increase variability in rodent research studies. Curr Opin Behav Sci. 2018;23:143–149. doi: 10.1016/j.cobeha.2018.06.016
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. doi: 10.1371/journal.pbio.1000412
   PubMed Web of Science ®Google Scholar
• Jackson SJ, Andrews N, Ball D, et al. Does age matter? The impact of rodent age on study outcomes. Lab Anim. 2017;51(2):160–169. doi: 10.1177/0023677216653984
   PubMedGoogle Scholar
• Flurkey K, Currer JM, Harrison DE. The mouse in aging research. In: The mouse in biomedical research (2nd ed). Fox J, et al, editor. Burlington, MA: American College Laboratory Animal Medicine (Elsevier); 2007. p. 637–672. doi: 10.1016/B978-012369454-6/50074-1
   Google Scholar
• Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med. 2013;4(6):624–630.
   PubMedGoogle Scholar
• Zhao Y, Fu JL, Li YL, et al. Epidemiology and clinical characteristics of patients with glaucoma: an analysis of hospital data between 2003 and 2012. Indian J Ophthalmol. 2015;63(11):825–831. doi: 10.4103/0301-4738.171963
   PubMed Web of Science ®Google Scholar
• Xu Q, Rydz C, Nguyen Huu VA, et al. Stress induced aging in mouse eye. Aging Cell. 2022;21(12):e13737. doi: 10.1111/acel.13737
   PubMed Web of Science ®Google Scholar
• John SWM, Smith SS, Savinova RS, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951–962.
   PubMed Web of Science ®Google Scholar
• Kawai S, Vora S, Das S, et al. Modeling of risk factors for the degeneration of retinal ganglion cells after ischemia/reperfusion in rats: effects of age, caloric restriction, diabetes, pigmentation. FASEB J. 2001;15:1285–1287. doi: 10.1096/fj.00-0666fje
   PubMed Web of Science ®Google Scholar
• Danias J, Lee KC, Zamora MF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice. Comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci. 2003;44(12):5151–5162. doi: 10.1167/iovs.02-1101
   PubMed Web of Science ®Google Scholar
• Nishinaka A, Tanaka M, Aoshima K, et al. The pathological association between the anterior eye segment and the retina in a murine model of neovascular glaucoma. FASEB J. 2022;36(6):e22323. doi: 10.1096/fj.202101917R
   PubMed Web of Science ®Google Scholar
• Wan P, Huang S, Luo Y, et al. Reciprocal regulation between lncRNA ANRIL and p15 in steroid-induced glaucoma. Cells. 2022;11(9):1468. doi: 10.3390/cells11091468
   PubMed Web of Science ®Google Scholar
• Razali N, Agarwal R, Agarwal P, et al. Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs. Eur J Pharmacol. 2015;749:73–80. doi: 10.1016/j.ejphar.2014.11.029
   PubMed Web of Science ®Google Scholar
• Marcus AJ, Iezhitsa I, Agarwal R, et al. Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension. Eur J Pharmacol. 2019;850:75–87. doi: 10.1016/j.ejphar.2019.01.059
   PubMed Web of Science ®Google Scholar
• Mohd Nasir NA, Agarwal R, Krasilnikova A, et al. Effect of dexamethasone on the expression of MMPs, adenosine A1 receptors and NFKB by human trabecular meshwork cells. J Basic Clin Physiol Pharmacol. 2020;31(6): doi: 10.1515/jbcpp-2019-0373
   PubMedGoogle Scholar
• Lee KM, Song DY, Kim SH. Effect of strain on rodent glaucoma models: magnetic bead injection versus hydrogel injection versus circumlimbal suture. Transl Vis Sci Technol. 2022;11(9):31. doi: 10.1167/tvst.11.9.31
   PubMed Web of Science ®Google Scholar
• Zahavi A, Friedman Gohas M, Sternfeld A, et al. Histological and molecular characterization of glaucoma model induced by one or two injections of microbeads to the anterior chamber of mice. Int Ophthalmol. 2022;42(12):3763–3775. doi: 10.1007/s10792-022-02372-9
   PubMed Web of Science ®Google Scholar
• Gupta V, Chitranshi N, Gupta V, et al. TrkB receptor agonist 7,8 dihydroxyflavone is protective against the inner retinal deficits induced by experimental glaucoma. Neuroscience. 2022;490:36–48. doi: 10.1016/j.neuroscience.2022.01.020
   PubMed Web of Science ®Google Scholar
• Mysona BA, Zhao J, De Greef O, et al. Sigma-1 receptor agonist, (+)-pentazocine, is neuroprotective in a Brown Norway rat microbead model of glaucoma. Exp Eye Res. 2023;226:109308. doi: 10.1016/j.exer.2022.109308
   PubMed Web of Science ®Google Scholar
• Sappington RM, Carlson BJ, Crish SD, et al. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci. 2010 Jan;51(1):207–216. doi: 10.1167/iovs.09-3947
   PubMed Web of Science ®Google Scholar
• Rodrigo MJ, Bravo-Osuna I, Subias M, et al. Tunable degrees of neurodegeneration in rats based on microsphere-induced models of chronic glaucoma. Sci Rep. 2022;12(1):20622. doi: 10.1038/s41598-022-24954-4
   PubMed Web of Science ®Google Scholar
• Aragón-Navas A, Rodrigo MJ, Garcia-Herranz D, et al. Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres. Drug Deliv. 2022;29(1):2357–2374. doi: 10.1080/10717544.2022.2096712
   PubMed Web of Science ®Google Scholar
• Tan Z, Guo Y, Shrestha M, et al. Microglia depletion exacerbates retinal ganglion cell loss in a mouse model of glaucoma. Exp Eye Res. 2022;225:109273. doi: 10.1016/j.exer.2022.109273
   PubMed Web of Science ®Google Scholar
• Guo M, Zhu Y, Shi Y, et al. Inhibition of ferroptosis promotes retina ganglion cell survival in experimental optic neuropathies. Redox Biol. 2022;58:102541. doi: 10.1016/j.redox.2022.102541
   PubMed Web of Science ®Google Scholar
• Nam MH, Stankowska DL, Johnson GA, et al. Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma. Cell Death Dis. 2022;13(11):958. doi: 10.1038/s41419-022-05407-2
   PubMed Web of Science ®Google Scholar
• Visuvanathan S, Baker AN, Lagali PS, et al. XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma. Gene Ther. 2022;29(3–4):147–156. doi: 10.1038/s41434-021-00281-7
   PubMed Web of Science ®Google Scholar
• Wang DD, Gao FJ, Zhang XJ, et al. Nobiletin protects retinal ganglion cells in models of ocular hypertension in vivo and hypoxia in vitro. Lab Invest. 2022;102(11):1225–1235. doi: 10.1038/s41374-022-00813-8
   PubMed Web of Science ®Google Scholar
• Madhoun S, Martins MTC, Korneva A, et al. Effects of experimental glaucoma in Lama1nmf223 mutant mice. Exp Eye Res. 2023;226:109341. doi: 10.1016/j.exer.2022.109341
   PubMed Web of Science ®Google Scholar
• Ribeiro M, McGrady NR, Baratta RO, et al. Intraocular delivery of a collagen mimetic peptide repairs retinal ganglion cell axons in chronic and acute injury models. Int J Mol Sci. 2022;23(6):2911. doi: 10.3390/ijms23062911
   PubMed Web of Science ®Google Scholar
• Zhu T, Huang X, Peng S, et al. Ultrasound targeted microbubble destruction promotes the therapeutic effect of HUMSC transplantation on glaucoma-caused optic nerve injury in rabbits. Transl Vis Sci Technol. 2022;11(5):12. doi: 10.1167/tvst.11.5.12
   Web of Science ®Google Scholar
• Morgan JE, Tribble JR. Microbead models in glaucoma. Exp Eye Res. 2015;141:9–14. doi: 10.1016/j.exer.2015.06.020
   PubMed Web of Science ®Google Scholar
• Frankfort BJ, Khan AK, Tse DY, et al. Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma. Invest Ophthalmol Vis Sci. 2013;54(1):762–770. doi: 10.1167/iovs.12-10581
   PubMed Web of Science ®Google Scholar
• Rodrigo MJ, Garcia-Herranz D, Subias M, et al. Chronic glaucoma using biodegradable microspheres to induce intraocular pressure elevation. Six-month follow-up. Biomedicines. 2021 Jun 16;9(6):682. doi: 10.3390/biomedicines9060682
   PubMed Web of Science ®Google Scholar
• Hughes E, Spry P, Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma. 2003 Jun;12(3):232–236. doi: 10.1097/00061198-200306000-00009
   PubMed Web of Science ®Google Scholar
• Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000 Apr;9(2):134–142. doi: 10.1097/00061198-200004000-00002.
   PubMed Web of Science ®Google Scholar
• Arfuzir NN, Lambuk L, Jafri AJ, et al. Protective effect of magnesium acetyltaurate against endothelin-induced retinal and optic nerve injury. Neuroscience. 2016;325:153–164. doi: 10.1016/j.neuroscience.2016.03.041
   PubMed Web of Science ®Google Scholar
• Arfuzir NNN, Agarwal R, Iezhitsa I, et al. Dose-dependent effects of endothelin-1 on retinal and optic nerve morphology in Sprague Dawley rats. Neurochem J. 2019;13:73–80. doi: 10.1134/S1819712419010045
   Google Scholar
• Nor Arfuzir NN, Agarwal R, Iezhitsa I, et al. Effect of magnesium acetyltaurate and taurine on endothelin1-induced retinal nitrosative stress in rats. Curr Eye Res. 2018;43(8):1032–1040. doi: 10.1080/02713683.2018.1467933
   PubMed Web of Science ®Google Scholar
• Nor Arfuzir NN, Agarwal R, Iezhitsa I, et al. Taurine protects against retinal and optic nerve damage induced by endothelin-1 in rats via antioxidant effects. Neural Regen Res. 2018;13(11):2014–2021. doi: 10.4103/1673-5374.239450
   PubMed Web of Science ®Google Scholar
• Smedowski A, Pietrucha-Dutczak M, Kaarniranta K, et al. A rat experimental model of glaucoma incorporating rapid-onset elevation of intraocular pressure. Sci Rep. 2014;4:5910. doi: 10.1038/srep05910
   PubMed Web of Science ®Google Scholar
• Wang N, Yang Y, Liu Y, et al. Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury. Int Immunopharmacol. 2022;112:109242. doi: 10.1016/j.intimp.2022.109242
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang R, Wu J. Inhibition of the NR2B-PSD95 interaction exerts neuroprotective effects on retinal ischemia-reperfusion injury. Neuroscience. 2022;490:89–99. doi: 10.1016/j.neuroscience.2022.02.030
   PubMed Web of Science ®Google Scholar
• Rahimi M, Leahy S, Matei N, et al. Impairments of retinal hemodynamics and oxygen metrics in ocular hypertension-induced ischemia-reperfusion. Exp Eye Res. 2022;225:109278. doi: 10.1016/j.exer.2022.109278
   PubMed Web of Science ®Google Scholar
• Zhang M, Yang J, Ji K, et al. Inhibition of p66Shc attenuates retinal ischemia-reperfusion injury-induced damage by activating the akt pathway. Exp Eye Res. 2022;220:109082. doi: 10.1016/j.exer.2022.109082
   PubMed Web of Science ®Google Scholar
• Lee D, Nakai A, Miwa Y, et al. Retinal degeneration induced in a mouse model of ischemia-reperfusion injury and its management by pemafibrate treatment. FASEB J. 2022;36(9):e22497. doi: 10.1096/fj.202200455RRR
   PubMed Web of Science ®Google Scholar
• Yao F, Peng J, Zhang E, et al. Pathologically high intraocular pressure disturbs normal iron homeostasis and leads to retinal ganglion cell ferroptosis in glaucoma. Cell Death Differ. 2023;30(1):69–81. doi: 10.1038/s41418-022-01046-4
   PubMed Web of Science ®Google Scholar
• Bui BV, Batcha AH, Fletcher E, et al. Relationship between the magnitude of intraocular pressure during an episode of acute elevation and retinal damage four weeks later in rats. Plos One. 2013;8(7):e70513. doi: 10.1371/journal.pone.0070513
   PubMed Web of Science ®Google Scholar
• Hu L, Xu Y, Meng H. Development and evaluation of puerarin loaded-albumin nanoparticles thermoresponsive in situ gel for ophthalmic delivery. Drug Des Devel Ther. 2022;16:3315–3326. doi: 10.2147/DDDT.S374061
   PubMed Web of Science ®Google Scholar
• Kodati B, McGrady NR, Jefferies HB, et al. Oral administration of a dual ETA/ETB receptor antagonist promotes neuroprotection in a rodent model of glaucoma. Mol Vis. 2022;28:165–177.
   PubMed Web of Science ®Google Scholar
• Jiang J, Xu J, Tao Y, et al. A novel and reversible experimental primate ocular hypertension model: blocking Schlemm’s canal. Ophthalmic Res. 2022;354–366.
   Web of Science ®Google Scholar
• Tonner H, Hunn S, Auler N, et al. A monoclonal anti-HMGB1 antibody attenuates neurodegeneration in an experimental animal model of glaucoma. Int J Mol Sci. 2022;23(8):4107. doi: 10.3390/ijms23084107
   PubMed Web of Science ®Google Scholar
• Tonner H, Hunn S, Auler N, et al. Dynamin-like protein 1 (DNML1) as a molecular target for antibody-based immunotherapy to treat glaucoma. Int J Mol Sci. 2022;23(21):13618. doi: 10.3390/ijms232113618
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu L, Zhang Z. TYRP1 protects against the apoptosis and oxidative stress of retinal ganglion cells by binding to PMEL. Ocul Immunol Inflamm. 2022;31(5):1–11. doi: 10.1080/09273948.2022.2081862
   Web of Science ®Google Scholar
• Léger-Charnay E, Gambert S, Martine L, et al. Retinal cholesterol metabolism is perturbated in response to experimental glaucoma in the rat. Plos One. 2022;17(3):e0264787. doi: 10.1371/journal.pone.0264787
   PubMed Web of Science ®Google Scholar
• Chaudhary P, Stowell C, Reynaud J, et al. Optic nerve head myelin-related protein, GFAP, and Iba1 alterations in non-human primates with early to moderate experimental glaucoma. Invest Ophthalmol Vis Sci. 2022;63(11):9. doi: 10.1167/iovs.63.11.9
   PubMed Web of Science ®Google Scholar
• Gu L, Kwong JM, Caprioli J, et al. DNA and RNA oxidative damage in the retina is associated with ganglion cell mitochondria. Sci Rep. 2022;12(1):8705. doi: 10.1038/s41598-022-12770-9
   PubMed Web of Science ®Google Scholar
• Moshiri A, Fang F, Zhuang P, et al. Silicone oil-induced glaucomatous neurodegeneration in rhesus macaques. Int J Mol Sci. 2022;23(24):15896. doi: 10.3390/ijms232415896
   PubMed Web of Science ®Google Scholar
• Huang S, Huang P, Yu H, et al. Hydrogen sulfide supplement preserves mitochondrial function of retinal ganglion cell in a rat glaucoma model. Cell Tissue Res. 2022;389(2):171–185. doi: 10.1007/s00441-022-03640-x
   PubMed Web of Science ®Google Scholar
• Noailles A, Kutsyr O, Mayordomo-Febrer A, et al. Sodium hyaluronate-induced ocular hypertension in rats damages the direction-selective circuit and inner/outer retinal plexiform layers. Invest Ophthalmol Vis Sci. 2022;63(5):2. doi: 10.1167/iovs.63.5.2
   PubMed Web of Science ®Google Scholar
• Pasák M, Vanišová M, Tichotová L, et al. Mitochondrial dysfunction in a high intraocular pressure-induced retinal ischemia minipig model. Biomolecules. 2022;12(10):1532. doi: 10.3390/biom12101532
   PubMed Web of Science ®Google Scholar
• Lin J, Xue J, Xu Q, et al. In situ-crosslinked hydrogel-induced experimental glaucoma model with persistent ocular hypertension and neurodegeneration. Biomater Sci. 2022;10(17):5006–5017. doi: 10.1039/d2bm00552b
   PubMed Web of Science ®Google Scholar
• Pu L, Zhou R, Li Q, et al. Distribution of pigment particles in aqueous drainage structures in a DBA/2J mouse model of pigmentary glaucoma. Invest Ophthalmol Vis Sci. 2022;63(6):2. doi: 10.1167/iovs.63.6.2
   PubMed Web of Science ®Google Scholar
• Muir ER, Chandra SB, Narayanan D, et al. Effects of chronic mild hyperoxia on retinal and choroidal blood flow and retinal function in the DBA/2J mouse model of glaucoma. Plos One. 2022;17(3):e0266192. doi: 10.1371/journal.pone.0266192
   PubMed Web of Science ®Google Scholar
• Smith JC, Zhang KY, Sladek A, et al. Loss of retinogeniculate synaptic function in the DBA/2J mouse model of glaucoma. eNeuro. 2022;9(6). ENEURO.0421-22.2022. doi: 10.1523/ENEURO.0421-22.2022
   Web of Science ®Google Scholar
• Fraenkl SA, Simon Q, Yucel Y, et al. Impact of cerebral hypoperfusion-reperfusion on optic nerve integrity and visual function in the DBA/2J mouse model of glaucoma. BMJ Open Ophthalmol. 2022;7(1):e001078. doi: 10.1136/bmjophth-2022-001078
   PubMed Web of Science ®Google Scholar
• Nishijima E, Honda S, Kitamura Y, et al. Vision protection and robust axon regeneration in glaucoma models by membrane-associated Trk receptors. Mol Ther. 2023;31(3):810–824. doi: 10.1016/j.ymthe.2022.11.018
   PubMed Web of Science ®Google Scholar
• Chen W, Liu P, Liu D, et al. Maprotiline restores ER homeostasis and rescues neurodegeneration via Histamine receptor H1 inhibition in retinal ganglion cells. Nat Commun. 2022;13(1):6796. doi: 10.1038/s41467-022-34682-y
   PubMed Web of Science ®Google Scholar
• Fang F, Zhuang P, Feng X, et al. NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function. Mol Ther. 2022;30(4):1421–1431. doi: 10.1016/j.ymthe.2022.01.035
   PubMed Web of Science ®Google Scholar
• Xie F, Li Z, Yang N, et al. Inhibition of heat shock protein B8 alleviates retinal dysfunction and ganglion cells loss via autophagy suppression in mouse axonal damage. Invest Ophthalmol Vis Sci. 2022;63(6):28. doi: 10.1167/iovs.63.6.28
   Web of Science ®Google Scholar
• Peng J, Jin J, Su W, et al. High-mobility group box 1 inhibitor BoxA alleviates neuroinflammation-induced retinal ganglion cell damage in traumatic optic neuropathy. Int J Mol Sci. 2022;23(12):6715. doi: 10.3390/ijms23126715
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang Y, Qi X, et al. GAD1 alleviates injury-induced optic neurodegeneration by inhibiting retinal ganglion cell apoptosis. Exp Eye Res. 2022;223:109201. doi: 10.1016/j.exer.2022.109201
   PubMed Web of Science ®Google Scholar
• Zloto O, Zahavi A, Richard S, et al. Neuroprotective effect of azithromycin following induction of optic nerve crush in wild type and immunodeficient mice. Int J Mol Sci. 2022;23(19):11872. doi: 10.3390/ijms231911872
   PubMed Web of Science ®Google Scholar
• Lypka KR, Carmy-Bennun T, Garces KN, et al. Assessment of outer retinal thickness and function in mice after experimental optic nerve trauma. BMC Ophthalmol. 2022;22(1):502. doi: 10.1186/s12886-022-02737-9
   PubMed Web of Science ®Google Scholar
• Olakowska E, Rodak P, Pacwa A, et al. Surgical menopause impairs retinal conductivity and worsens prognosis in an acute model of rat optic neuropathy. Cells. 2022;11(19):3062. doi: 10.3390/cells11193062
   PubMed Web of Science ®Google Scholar
• Li H, Behnammanesh G, Wu Z, et al. Echium amoenum L. ethanol extract protects retinal ganglion cell after glutamate and optic nerve crush injury. Dis Markers. 2022;2022:3631532. doi: 10.1155/2022/3631532
   PubMedGoogle Scholar
• Wang P, Luo S, Shen C, et al. Protective effect of epothilone D against traumatic optic nerve injury in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(4):575–583. doi: 10.12122/j.issn.1673-4254.2022.04.14
   PubMedGoogle Scholar
• Lambuk L, Jafri AJ, Arfuzir NN, et al. Neuroprotective effect of magnesium acetyltaurate against NMDA-induced excitotoxicity in rat retina. Neurotox Res. 2017;31(1):31–45. doi: 10.1007/s12640-016-9658-9
   PubMed Web of Science ®Google Scholar
• Jafri AJA, Arfuzir NNN, Lambuk L, et al. Protective effect of magnesium acetyltaurate against NMDA-induced retinal damage involves restoration of minerals and trace elements homeostasis. J Trace Elem Med Biol. 2017;39:147–154. doi: 10.1016/j.jtemb.2016.09.005
   PubMed Web of Science ®Google Scholar
• Jafri AJA, Agarwal R, Iezhitsa I, et al. Taurine protects against NMDA-induced retinal damage by reducing retinal oxidative stress. Amino Acids. 2019;51(4):641–646. doi: 10.1007/s00726-019-02696-4
   PubMed Web of Science ®Google Scholar
• Lambuk L, Jafri AJA, Iezhitsa I, et al. Dose-dependent effects of NMDA on retinal and optic nerve morphology in rats. Int J Ophthalmol. 2019;12(5):746–753. doi: 10.18240/ijo.2019.05.08
   PubMed Web of Science ®Google Scholar
• Abd Ghapor AA, Iezhitsa I, Agarwal R, et al. Intravitreal trans-resveratrol ameliorates NMDA-Induced optic nerve and retinal injury. Curr Eye Res. 2022;47(6):866–873. doi: 10.1080/02713683.2022.2033270
   PubMed Web of Science ®Google Scholar
• Abd Ghapor AA, Abdul Nasir NA, Iezhitsa I, et al. Neuroprotection by trans-resveratrol in rats with N-methyl-D-aspartate (NMDA)–induced retinal injury: insights into the role of adenosine A1 receptors. Neurosci Res. 2023;193:S1–12. doi: 10.1016/j.neures.2023.02.004
   PubMed Web of Science ®Google Scholar
• Brahma MM, Takahashi K, Namekata K, et al. Genetic inhibition of collapsin response mediator protein-2 phosphorylation ameliorates retinal ganglion cell death in normal-tension glaucoma models. Genes Cells. 2022;27(8):526–536. doi: 10.1111/gtc.12971
   PubMed Web of Science ®Google Scholar
• Crossley NA, Sena E, Goehler J, et al. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke. 2008;39(3):929–934. doi: 10.1161/STROKEAHA.107.498725
   PubMed Web of Science ®Google Scholar
• Pound P, Ebrahim S, Sandercock P, et al.; Reviewing Animal Trials Systematically (RATS) Group. Where is the evidence that animal research benefits humans? BMJ. 2004;328(7438):514–5147. doi: 10.1136/bmj.328.7438.514.
   PubMed Web of Science ®Google Scholar
• Pound P, Ritskes-Hoitinga M. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. J Transl Med. 2018;16(1):304. doi: 10.1186/s12967-018-1678-1
   PubMedGoogle Scholar